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Up-regulation of activation-
induced cytidine deaminase and its 
strong expression in extra-germinal 
centres in IgG4-related disease
Yuka Gion1,2, Mai Takeuchi3, Rei Shibata1, Katsuyoshi Takata1, Tomoko Miyata-Takata1, 
Yorihisa Orita4, Tomoyasu Tachibana5, Tadashi Yoshino1 & Yasuharu Sato1,2
Immunoglobulin (Ig) G4-related disease (IgG4-RD) is a systemic disorder involving benign mass 
formation due to fibrosis and intense lymphoplasmacytosis; the chronic inflammation associated 
with the disease might also contribute to oncogenesis. Activation-induced cytidine deaminase (AID), 
normally expressed in germinal centre activated B-cells, is an enzyme that edits DNA/RNA and induces 
somatic hypermutation and Ig class switching. AID expression is strictly controlled under physiological 
conditions; however, chronic inflammation and some infectious agents induce its up-regulation. 
AID is overexpressed in various cancers and may be important in chronic inflammation-associated 
oncogenesis. We examined AID expression in IgG4-related sialadenitis (n = 14), sialolithiasis (non-
specific inflammation, n = 13), and normal submandibular glands (n = 13) using immunohistochemistry 
and quantitative real-time polymerase chain reaction (qPCR). Immunohistochemistry revealed 
significantly more AID-expressing cells in IgG4-related sialadenitis than in sialolithiasis or normal 
submandibular gland samples (P = 0.02 and P < 0.01, respectively); qPCR yielded similar results. 
Thus, AID was significantly more up-regulated and had higher expression in extra-germinal centres in 
IgG4-RD than in non-specific inflammation or normal conditions. This report suggests that IgG4-RD 
has several specific causes of AID up-regulation in addition to inflammation. Furthermore, chronic 
inflammation-associated AID-mediated oncogenesis is possible in IgG4-RD.
Immunoglobulin (Ig) G4-related disease (IgG4-RD) is a systemic disorder characterized by the formation of 
benign masses and tumefactive lesions in various organs1. Histological observations of affected tissues exhibit 
dense fibrosis and infiltration of large numbers of lymphocytes, plasma cells, and eosinophils2. In patients with 
these types of diseases, many plasma cells express IgG4 and its serum levels are highly elevated2. The pathogenesis 
of IgG4-RD remains unclear; however, up-regulation of T-helper 2 (Th2) and regulatory T (Treg) cell cytokines, 
including interleukin 4 (IL4), IL5, IL10, IL13, and transforming growth factor-beta 1 (TGFB1), in affected organs 
is thought to be important3.
Patients with IgG4-RD appear to be at higher risk of developing malignancies than the general population; 
lymphomas and cancers of the colon, lung, breast, and pancreas, have been reported among those with this dis-
ease4,5. Moreover, the oncogenesis of extranodal marginal zone lymphomas, involving mucosa-associated lym-
phoid tissue (MALT lymphomas), has also been documented in patients with this disease6,7. Hence, IgG4-RD 
has been suggested to induce malignancies. Given the systemic inflammatory nature of this disorder, chronic 
inflammation may be important in such oncogenesis.
Activation-induced cytidine deaminase (AID) is a member of the cytidine deaminase family of enzymes 
that modify nucleotides to cause various mutations8. AID plays a crucial role in B-cell maturation and is nor-
mally expressed in activated B-cells in germinal centres8. This enzyme induces somatic hypermutations in the Ig 
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variable region and gives rise to mutations in the constant region to cause Ig class switching from IgM to IgG, IgA, 
or IgE. Under normal conditions, AID expression is strictly regulated to prevent unfavourable somatic mutations. 
However, there have been many reports of inappropriate AID expression in various cancers9,10. In addition to 
B-cells, AID expression can be induced in various epithelial tissues due to chronic inflammation and infection11. 
Up-regulation of AID during inflammatory conditions is believed to cause uncontrolled somatic mutations of 
various genes, resulting in chronic inflammation-associated cancers12.
The mechanism underlying oncogenesis in IgG4-RD remains unclear, but AID up-regulation due to chronic 
inflammation could be a contributing factor. Despite this, AID expression in IgG4-RD has not been previously 
examined. Therefore, in this study, we investigated the expression of AID in IgG4-related sialadenitis.
Results
AID-expressing cells. AID immunohistochemical staining revealed many AID-positive lymphoid or 
plasma cells in both the germinal centres and in the interfollicular areas of IgG4-related sialadenitis samples 
(Fig. 1a). The ductal epithelia in such specimens were also positive for AID (Fig. 1b). Various numbers of AID-
expressing cells were observed in sialolithiasis specimens (Fig. 1c); however, none were noted in normal (control) 
tissues (Fig. 1d). The AID staining intensity index was significantly higher in IgG4-related sialadenitis samples [9 
(64%), 3 (21%), 2 (14%), and 0 (0%) cases were categorized as 3+, 2+, 1+, and 0, respectively] than in sialolithi-
asis [3 (23%), 3 (23%), 3 (23%), and 4 (31%) cases, respectively] (P = 0.02) or normal control [all 13 (100%) cases 
were categorized as 0] (P < 0.01) (Fig. 2).
Quantitative analysis of AID expression. Quantitative real-time polymerase chain reaction (qPCR) 
revealed that AID expression in IgG4-RD was significantly higher than that in sialolithiasis (P = 0.02) or normal 
submandibular gland (P < 0.01) (Fig. 3). AID expression was also significantly higher in sialolithiasis than in 
normal control tissues (P < 0.01).
Figure 1. Immunohistochemical staining of activation-induced cytidine deaminase (AID). (a) IgG4-related 
sialadenitis (×100), (b) IgG4-related sialadenitis (×400). Greater numbers of strongly AID-positive cells were 
noted in IgG4-related sialadenitis than in those from healthy controls or patients with sialolithiasis. Ductal 
epithelia in IgG4-related sialadenitis were also positive for AID. In addition to AID-positivity in the germinal 
centres of AID-positive cells, the interfollicular areas were also AID-positive. AID-positive interfollicular 
areas were observed in lymphoid cells, plasma cells, and plasmacytoid cells. (c) Sialolithiasis (×400). Although 
lymphoid cell infiltration was observed in patients with sialolithiasis, fewer AID-positive cells were observed 
compared with IgG4-related sialadenitis. (d) Normal submandibular gland (×400). No AID-positive cells were 
noted in normal tissue.
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Discussion
The aetiologies of IgG4-RD and its underlying oncogenic mechanisms remain largely unknown. Some studies 
have failed to find any relationship between IgG4-RD and cancer13,14, whereas others have shown malignancies 
develop in a subset of patients with IgG4-RD15. Hence, the relationship between the two remains controversial. 
However, the frequency of KRAS mutations has been reported to be higher in the pancreatic and bile ducts 
and gastrointestinal tracts of patients with autoimmune pancreatitis16,17. This indicates that IgG4-RD is asso-
ciated with somatic oncogene mutations and may induce malignancies in various organs. The development of 
MALT lymphomas in patients with IgG4-RD has also been documented6,7. Interestingly, unlike conventional 
MALT lymphomas, those arising in patients with IgG4-RD are associated with up-regulation of Th2 and Treg 
cytokines18. Thus, these cytokines may be important in the pathogenesis of IgG4-RD; hence, MALT lymphoma 
may develop due to Th2/Treg-predominated chronic inflammation.
Various cancers occur in association with chronic inflammation. Infectious agents such as Helicobacter pylori 
and hepatitis B and C viruses are known to induce cancers related to chronic inflammation. Additionally, several 
non-infectious inflammatory conditions, such as inflammatory bowel disease, primary sclerosing cholangitis, 
and chronic pancreatitis, are also associated with malignancies12. The accumulation of genetic and epigenetic 
alterations, caused by chronic inflammation, is thought to be important in inflammation-associated oncogenesis. 
The majority of nucleotide alterations in cancers, including inflammation-associated cancers, involve cytosine 
(C)/guanine (G) to thymine (T)/adenine (A) transitions19. AID deaminates C residues to uracil (U), resulting 
in U/G mismatches. Without DNA repair, each U/G pair is replicated as T/A instead of C/G, representing the 
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Figure 2. Intensity scores of specimens following immunohistochemical staining for activation-induced 
cytidine deaminase (AID). Compared with sialolithiasis and normal submandibular gland, AID was more 
strongly expressed in IgG4-related sialadenitis.
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Figure 3. Quantitative analysis of activation-induced cytidine deaminase (AID) expression. AID expression 
in IgG4-related sialadenitis was significantly higher than in sialolithiasis and normal controls. *P < 0.05, 
**P < 0.01.
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most frequent nucleotide transition observed in cancers. U/G mismatches can also be recognized by uracil-DNA 
glycosylase, which induces various mutations at such sites. In addition, the mutS homolog 2/mutS homolog 6 
heterodimer can induce nucleotide mutations at both U/G and A/T sites near U/G mismatches. Hence, AID can 
induce several nucleotide sequence changes.
AID contributes to somatic hypermutation and Ig class switching under physiological conditions20. However, 
AID is also known to contribute to oncogenesis by inducing unfavourable somatic mutations and even chromo-
somal translocations. In hematopoietic malignancies, B-cell lymphomas with up-regulated AID have been shown 
to carry adverse mutations in genes, such as MYC, PIM1, and PAX5, as well as chromosomal abnormalities, 
including MYC/IGH rearrangements12,21–23. Aberrant AID expression in non-lymphoid cells has also been impli-
cated in the development of malignancies24, with its up-regulation inducing somatic mutations in genes, such as 
TP53, CDKN2A, and MYC24–27. A previous report also described the relationship between AID expression and 
IgH rearrangements in the peripheral blood of patients with Mikulicz disease28.
In this study, AID was shown to be up-regulated in IgG4-related sialadenitis. AID expression was also elevated 
in sialolithiasis, but to a significantly lesser extent. These results indicate the existence of a mechanism other than 
inflammation leading to elevated AID levels in patients with IgG4-RD. Under physiological conditions, AID is 
up-regulated by the nuclear factor-kappa B (NF-κB) signalling pathway in a T-cell-dependent or -independent 
manner29. The NF-κB pathway plays a pivotal role in oncogenesis by inducing tumour cell proliferation and 
suppressing apoptosis. Infectious agents, such as hepatitis C virus and H. pylori, can induce NF-κB signalling to 
up-regulate AID24,30. Further, the NF-κB-dependent induction of proinflammatory cytokine expression, includ-
ing that of tumour necrosis factor, is associated with AID overexpression11. In addition to these proinflammatory 
cytokines, the Th2/Treg cytokines IL-4, IL-13, and TGF-β are also known to result in elevated AID levels12,28,31. 
Further, Treg cytokines (IL-10 and TGFβ) and AID expression were significantly higher in the labial salivary 
glands of patients with IgG4-RD than in healthy controls or in those with Sjögren syndrome32. Hence, Th2/
Treg-mediated immunity in IgG4-RD may be responsible for the observed up-regulation of AID.
Given the existence of germinal centre hyperplasia in IgG4-related sialadenitis, AID up-regulation may par-
tially reflect increased numbers of germinal centres. However, histopathological examinations revealed many 
AID-positive lymphoid cells, plasma cells, and plasmacytoid cells in both the interfollicular areas and germi-
nal centres of submandibular gland specimens from patients with sialadenitis, indicating broader aberrant AID 
expression. Thus, the Th2/Treg cytokines produced by interfollicular T-cells or other immune cells may cause 
such aberrant up-regulation.
Conclusion
This study represents the first report of AID up-regulation and strong expression in extra-germinal centres in 
IgG4-RD. Thus, in this disease, AID may be up-regulated by Th2/Treg-predominated immunity and induce unfa-
vourable somatic mutations in various organs. As a result, AID may play an important role in oncogenesis in 
patients with IgG4-RD.
Methods
Samples. Formalin-fixed paraffin-embedded tissues from patients with IgG4-related sialadenitis (14 cases), 
sialolithiasis (non-specific inflammation, 13 cases), and normal submandibular glands (13 cases) were examined. 
The median patient ages were 67.5 (range, 60–82), 42 (11–85), and 75 (49–92) years, respectively; the male/female 
ratios were 12/2, 8/5, and 12/1, respectively. This study was approved by the institutional ethical review board of 
Okayama University. Because the samples were limited to excess human tissue, the ethical review board waived 
the need for written consent from the patients.
Histological examination and immunohistochemistry. All samples used in this study were surgically 
resected submandibular gland specimens. The specimens were fixed in 10% formaldehyde and embedded in 
paraffin, from which serial 3-μm-thick sections were cut and stained with haematoxylin and eosin. The sec-
tions were immunohistochemically stained, using an automated BOND-III stainer (Leica Biosystems, Wetzlar, 
Germany), using primary antibodies against AID (ab59361, polyclonal antibody, 1:150; Abcam, Cambridge, UK), 
IgG (A0423, polyclonal antibody, 1:20,000; DAKO, Glostrup, Denmark), and IgG4 (MC011, monoclonal anti-
body, 1:400; The Binding Site, Birmingham, UK).
Confirmation of histological IgG4-RD diagnosis. All cases were reviewed by two pathologists. In 
accordance with the consensus statement for the pathological assessment of IgG4-RD, different high-power fields 
(eyepiece, 10×; lens, 40×) were examined to calculate the average number of IgG4-positive cells per field (>100) 
and the IgG4-/IgG-positive cell ratio (>40%)33. All 14 cases were histologically consistent with IgG4-related 
sialadenitis.
Histological evaluation of AID expression. AID positivity was evaluated based on an intensity index, 
with scores of 0 (negative), 1+ (weakly positive), 2+ (moderately positive), and 3+ (strongly positive) (Fig. 4). 
Each specimen was evaluated by two pathologists.
qPCR. Total RNA was extracted from formalin-fixed, paraffin-embedded tissues with an miRNeasy FFPE kit 
(QIAGEN, Valencia, CA, USA), and complementary DNA was synthesized by reverse transcription PCR using 
a SuperScript VILO Master Mix kit (Invitrogen, Carlsbad, CA, USA), according to the manufacturers’ proto-
cols. For quantitative analyses, multiplex real-time PCR was performed using TaqMan Gene Expression Assays 
(Applied Biosystems, Foster City, CA, USA) and a StepOnePlus Real-Time PCR System (Applied Biosystems), 
following the manufacturers’ instructions. Specific primers and probes for AID (Hs00757808_m1) and actin beta 
(ACTB; Hs01060665_g1) were obtained from Applied Biosystems. The PCR cycling conditions were: 2 min at 
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50 °C, 20 s at 95 °C, and 40 cycles of 1 s at 95 °C and 20 s at 60 °C. Expression of AID was normalized to that of 
ACTB.
Statistical analysis. To compare AID expression among submandibular gland specimens from normal 
patients and those with IgG4-related sialadenitis or sialolithiasis, the Mann-Whitney U -test was applied (SPSS, 
version 24; IBM, Armonk, NY, USA). A P-value < 0.05 was considered statistically significant.
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